Significance of angiogenesis determination in pediatric solid tumors

Journal of Medical Sciences

Volumn 6, Issue 2, 2006, Pages 183-192

  El Habashy, Safinaz A ^a   Khalifa, Ahmed Samy ^a   Abdel Hadi, Salah S ^a   Dahaba, Nader A L ^a   Rasheed, Maha A ^a   Ilias, Tahany R ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Micro vessel density; Pediatric solid tumors; Tumor angiogenesis; Vascular endothelial growth factor

Indexed keywords

ANTINEOPLASTIC AGENT; VASCULOTROPIN;

ADOLESCENT; ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; CANCER MORTALITY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GANGLIONEUROMA; HEPATOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROVASCULATURE; NEPHROBLASTOMA; NEUROBLASTOMA; PROPORTIONAL HAZARDS MODEL; RETINOBLASTOMA; RHABDOMYOSARCOMA; SURVIVAL RATE; TUMOR BIOPSY; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 33645375406     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2006.183.192     Document Type: Article

References (55)

1. Abramsonm, L.P., P.E. Grundy, A.W. Rademaker, I. Helenowski, M. Cornwell,H.M. Katzenstein, M. Reynolds, R.M. Arensman and S.E. Crawford, 2003. Increased microvascular density predicts relapse in Wilms' tumor. J. Pediatr. Surg. Mar., 38: 325-330.
2. Barthlen, W., D. Flaadt, R. Girgert, J. Conzelmann, P. Schweizer, G. Zugmaier, M. Buck and C. Knabbe, 2003. Significance of heparin-binding growth factor expression on cells of solid pediatric tumors. J. Pediatr. Surg. Sep., 38: 1296-1304.
3. Bentas, W., W.D. Beecken, W. Glienke, J. Binder and H. Schuldes, 2003. Serum levels of basic fibroblast growth factor reflect disseminated disease in patients with testicular gertn cell tumors. Urol. Res. Feb., 30: 390-393.
4. Bosari, S., A.K. Lee, R.A. DeLellis, B.D. Wiley, G.J. Heatley and M.L. Silverman, 1992. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol., 23: 755-761.
5. Brodeur, G.M., J. Pritchard, F. Berthold, N.L. Carlsen, V. Castel, R.P. Castelberry, B. De Bernardi, A.E. Evans, M. Favrot and F. Hedborg, 1993. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J. Clinic. Oncol., 11: 1466-1477.
6. Bredel, M., R.D. Pollack, J.W. Campbell and R.L. Hamilton, 1997. Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high grade gliomas. Clin. Can. Res., 3: 2157-2164
7. Brown, J., G. Perilongo, E. Shafford, J. Keeling, J. Pritchard, P. Brock, C. Dicks-Mireaux, A. Phillips, A. Vos and J. Plaschkes, 2000. Pretreatment prognostic factors for children with hepatoblastoma- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur. J. Cancer, 36: 1418-1425.
8. Castleberry, R.P., J.J. Shuste and E.I. Smith, 1994. The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. J. Clin. Oncol., 12: 2378-2381.
9. Canete, A., S. Navarro, J. Bermudez, A. Pelli and V. Castel, 2000. Llombart-Bosch A:. Angiogenesis in neuroblastoma: relationship to survival and other prognostic factors in a cohort of neuroblastoma patients. J. Clin. Oncol., 18: 27-34.
10. Couvelard, A., D. O'Toole, H. Turley, R. Leek, A. Sauvanet, C. Degott, P. Ruszniewski, J. Belghiti, A.L. Harris, K. Gatter and F. Pezzella, 2005. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: Negative correlation of microvascular density and VEGF expression with tumour progression. Br. J. Cancer, 92: 94-101.
11. D'Angio, G.J., N. Breslow, J.B. Beckwith, A. Evans, H.Baum, A. deLorimier, D. Fernbach, E. Hrabovsky, B. Jones and P. Kelalis et al., 1989. Treatment of Wilms' tumor: results of the third National Wilms' Tumor Study. Cancer, 64: 349-360.
12. Diniz, G., S. Aktas, R. Ortac, A. Erbay, C. Vergin and M. Ergin, 2004. Alternative prognostic factors in pediatric embryonal rhabdomyosarcoma: Nm23 expression, proliferative activity and angiogenesis. Turk. J. Pediatr., 46: 239-244.
13. Dina, A., V. Zahava and M. Iness, 2005. The role of vascular endothelial growth factor in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol., 27: 62-66.
14. Dirix, L.Y., P.B. Vermeulen, A. Pawinski, A. Prové, I. Benoy, C. De Pooter, M. Martin and A.T. Van Oosterom, 1997. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and endothelial growth factor in sera of cancer patients. Br. J. Cancer, 76: 238-243.
15. Dosquet, C., M.C. Coudert, E. Lepage, J. Cabane and F. Richard, 1997. Are angiogenic factors, cytokines and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma. Clin. Cancer Res., 3: 2451-2458.
16. Dulak, J. and A. Jozkowicz, 2003. Antioxid. Redox Signal., 5: 123-132.
17. Eggert, A., N. Ikegaki, J. Kwiatkowski, H. Zhao, GM. Brodeur and B.P. Himelstein, 2000. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin. Cancer Res., 6: 1900-1908.
18. El-Houseini, M.E., S.A. Abdel-Azim, G.I. El-Desouky, S. Abdel-Hady, M.F. El-Hamad and A.M. Kamel, 2004. Clinical Significance of Vascular Endothelial Growth Factor (VEGF) in Sera of Patients with Pediatric Malignancies. J. Egypt Natl. Cancer, Inst., 16: 57-61.
19. Fakhari, M., D. Pullirsch, K. Paya, D. Abraham, R. Hofbauer and S. Aharinejad, 2002. Upregulation of vascular endothelial growth factor receptors is associated with advanced neuroblastoma. J. Pediatr. Surg., 37: 582-587.
20. Folkman, J., 1990. What is the evidence that tumors are angiogenesis dependent?. J. Natl. Cancer Inst. (Bethesda), 82: 4-6.
21. Folkman, J., 1992. The role of angiogenesis in tumor growth. Cancer Biol., 3: 65-71.
22. Folkman, J., 1997. Antiangiogenic studies highlight similarities between solid tumors and leukemia suggest a novel approach to therapy. Trends Oncol. Hematol, 5: 51-52.
23. Gasparini, G. and A.L. Harris, 1995. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool. J. Clin. Oncol., 13: 765-82.
24. Ghanem, M.A., G.J. van Steenbrugge, M.K. Sudaryo, R.B. Mathoera, J.M. Nijman and T.H. van der Kwast, 2003. Expression and prognostic relevance of Vascular Endothelial Growth Factor (VEGF) and its receptor (FLT-1) in nephroblastoma: J. Clin. Pathol., 56: 107-113.
25. Hamada, K., Y. Oike, N. Takakura, Y. Ito, L. Jussila, D.J. Dumont, K. Alitalo and T. Suda, 2000. VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis. Blood, 96: 3793-3800.
26. Hazar, B., S. Paydas, S. Zorludemir, B. Sahin and I. Tuncer, 2003. Prognostic significance of microvessel density and Vascular Endothelial Growth Factor (VEGF) expression in non-Hodgkin's lymphoma. Leuk. Lymphoma, 44: 2089-2093.
27. Henry, J.B., 1974. Clinical diagnosis and management by laboratory methoodes. WB Saunders and Company, Philadelphia, PA, pp: 365.
28. Howarth, C., D. Meyer, H.O. Hustu, W.W. Johnson, E. Shanks and C. Pratt, 1980. Stage-related combined modality treatment of retinoblastoma: Results of a prospective study. Cancer, 45: 851-858.
29. Höuöt O., 1985. Interpretation of Clinical Laboratory Tests. Eds. Siest, G., J. Henny, F. Schile and D.S. Yang. Biochemical Publications, pp: 220-34.
30. Huang, J., S.Z. Soffer, E.S. Kim, A. Yokoi, J.T. Moore, K.W. McCrudden, C. Manley, W. Middlesworth, K.O. Toole, C. Stolar, D.J. Yamashiro and J.J. Kandel, 2002. p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease. J. Pediatr. Surg, 37: 523-527.
31. Jendrassik, L. and P. Grof, 1938. Methods of serum total and direct bilirubin. Biochemistry, 2: 281-297.
32. Kline, N.E. and N. Sevier, 2003. Solid tumors in children. J. Pediatr. Nurs., 18: 96-102
33. Kayton, M.L., D.H. Rowe, K.M. O'Toole, R.B. Thompson, M.A. Schwarz, C.J. Stolar and J.J. Kandel, 1999. Metastasis correlates with production of vascular endothelial growth factor in a murine model of human Wilms' tumor. J. Pediatr. Surg., 34:743-747.
34. Lawrence W.Jr., D.M. Hays, R. Heyn and M. Tefft, W. Crist, M. Beltangady, W. Jr. Newton and M. Wharam, 1987. Lymphatic metastases with childhood rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study. Cancer, 60: 910-915.
35. Li, V.W., R.D. Folkerth, H. Watanabe, C. Yu, M. Rupnick, P. Barnes, R.M. Scott, P.M. Black, S.E. Sallan and J. Folkman, 1994. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet, 344: 82-86.
36. Lin, R.Y., P.A. Argenta, K.M. Sullivan and N.S. Adzick, 1995. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients. Clin. Cancer Res., 1: 327-331.
37. Langer, I., P. Vertongen, J. Perret, J. Fontaine, G. Atassi and P. Robberecht, 2000. Expression of Vascular Endothelial Growth Factor (VEGF) and VEGF receptors in human neuroblastomas. Med. Pediatr. Oncol., 34: 386-393.
38. Macchiarini, P., G. Fontanini, M.J. Hardin, F. Squartini and C.A. Angeletti, 1992. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet, 340: 145-146.
39. Messmer, E.P., T. Heinrich, W. Hopping, E. de Sutter, W. Havers and W. Sauerwein. 1991. Risk factors for metastases in patients with retinoblastoma. Ophthalmology, 98: 136-141.
40. Nguyen, M., 1997. Angiogenic factors as tumor markers. Invest New Drugs, 15: 29-37.
41. Patton, C.L. and S.R. Crouch, 1977. Spectrophotometric and kinetic investigation of Berthelot reaction for determination of ammonia. Ann. Chem., 49: 464-469.
42. Pavlakovic, H., V. Von Schutz, J. Ressler, E. Koscielniak, W. Havers and L. Schweigerer, 2001. Quantification of angiogenesis stimulators in children with solid malignancies. Intl. J. Cancer, 92: 756-760.
43. Parikh, A.A. and L.M. Ellis, 2004. The vascular endothelial growth factor family and its receptors. Hem. Onc. Clin. Nor. Am., 18: 951-971.
44. Pinkus, G.S., C.L. Ehteridge and E.M. O'Conner, 1986. Are keratin proteins a better tumor marker than epithelial membrane antigen? A comparative immunohistochemical study of various paraffin-embedded neoplasms using monoclonal antibodies. Am. J. Clin. Path, 85: 269-277.
45. Reitman, S. and S. Frankle, 1957. A calorimetric method for determination of serum oxalacetic and glutamic transaminases. Am. J. Clin. Pathol., pp: 28-36.
46. Rossler, J., T. Dietrich, H. Pavlakovic, L. Schweigerer, W. Havers, A. Schuler, N. Bornfeld and H. Schilling, 2004. Higher vessel densities in retinoblastoma with local invasive growth and metastasis. Am. J. Pathol., 164: 391-394.
47. Sampath, P., C.E. Weaver, A. Sungarian, S. Cortez, L. Alderson and E.G. Stopa, 2004. Cerebrospinal fluid (vascular endothelial growth factor) and serologic (recoverin) tumor markers for malignant glioma. Cancer Control, 11: 174-180.
48. Sell, L.S., 1990. Cancer markers of the 1990s. Clin. Lab. Med., 10: 1-37.
49. Sun, X.Y., Z.D. Wu, X.F. Liao and J.Y. Yuan, 2005. Tumor angiogenesis and its clinical significance in pediatric malignant liver tumor. World J. Gastroenterol., 11: 741-743.
50. Tabone, M.D., J. Landman-Parker, B. Arcil, M.C. Coudert, I. Gerota, M. Benbunan, G. Leverger and C. Dosquet, 2001. Are basic fibroblast growth fctor and vascular endothelial growth factor prognostic indicators on pediatric patients with malignant solid tumors? Clin. Can. Res., 7: 538-543
51. Tonini T., F. Rossi and P.P. Claudio, 2003. Molecular basis of angiogenesis and cancer. Oncogene., 22: 6549-6556.
52. Weidner, N., 1995. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol., 147: 9-19.
53. Wouters, B.G., M. Koritzinsky, R.K. Chiu, J. Theys, J. Buijsen and P. Lambin, 2003. Modulation of cell death in the tumor microenvironment. Semin. Radiat. Oncol., 13: 31-41.
54. Yamamoto, Y., M. Toi, S. Kondo, T. Matsumoto, H. Suzuki, M. Kitamura, K. Tsuruta, T. Taniguchi, A. Okamoto, T. Mori, M. Yoshida, T. Ikeda and T. Tominaga, 1996. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin. Cancer Res., 2: 821-826.
55. Yamamoto, S., I. Konishi, M. Mandai, H. Kuroda, T. Komatsu, K. Nanbu, H. Sakahara and T. Mori, 1997. Expression of Vascular Endothelial Growth Factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival and analysis of serum VEGF levels. Br. J. Cancer, 76: 1221-1227.